Clinical Trials Browser

NETWORK × Sorafenib × Genitourinary × Clear all

NCT00093457 2023-08-04

Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms